These are are the most common, and most reasonable, questions patients ask: “Should I start glaucoma eyedrops?” And this is followed by: “If my vision is fine and I feel normal, why do I need lifelong eye drops?”
The confusion arises because glaucoma does not cause symptoms until damage is advanced. By the time vision loss is noticeable, it is usually irreversible.
Feeling fine does not mean nothing is happening
Glaucoma damages the optic nerve slowly and silently.
Early damage affects peripheral vision and nerve fibres — areas the brain compensates for extremely well.
So patients often feel completely normal even while measurable progression is occurring on:
- Optic nerve examination
- OCT nerve fibre layer scans
- Visual field trend analysis
Glaucoma treatment is therefore preventive, not reactive.
Why should I start glaucoma eyedrops early
Glaucoma drops are not prescribed because vision is poor today.
They are prescribed because risk of future loss is high.
Starting treatment early:
- Lowers lifetime risk of vision disability
- Slows the rate of nerve damage
- Preserves long-term functional vision
- Reduces the chance of needing surgery later
The question is not “Do I feel fine?”
It is “What happens if I do nothing for 10–15 years?”
How doctors decide when to start glaucoma eyedrops
A recommendation to start treatment is usually based on:
- Optic nerve vulnerability
- Documented or suspected progression
- Family history of glaucoma
- Corneal thickness and pressure behaviour
- Age and expected lifetime risk
In some cases, careful observation is reasonable.
In others, waiting may cost irreplaceable nerve tissue.
Ruling out other contributors
Before committing to long-term therapy, responsible glaucoma care also considers:
- Neurological causes of optic nerve damage
- Ocular blood flow and perfusion
- Low nocturnal blood pressure
- Sleep apnea and systemic vascular factors
Symptoms like migraine, cold hands and feet, or peripheral vascular disease may influence risk even when eye pressure is modest.
When observation is a reasonable choice
Not every patient with elevated pressure or a suspicious optic nerve needs to start drops immediately. In some situations, careful structured observation is appropriate — provided it is genuinely structured, not simply doing nothing.
Observation may be reasonable when:
- Pressure is mildly elevated with no nerve damage and low risk profile
- The diagnosis is uncertain and more data is needed
- The patient is very elderly with limited life expectancy and stable findings
- Systemic health factors make certain medications unsuitable
Observation is only safe when it includes scheduled follow-up, repeat visual fields, and repeat OCT scans at defined intervals. It is not the same as being discharged and told to return only if something changes.
What glaucoma eyedrops actually do
Glaucoma eyedrops lower eye pressure. They do this in one of two ways: by reducing the amount of fluid the eye produces, or by improving the drainage of fluid out of the eye. Some drops do both.
They do not repair existing optic nerve damage. They do not improve vision that has already been lost. They work by reducing the ongoing pressure load on a nerve that may already be vulnerable.
This is why consistency matters. A drop that is prescribed but not taken every day provides partial protection at best. Glaucoma does not take days off.
A second opinion can bring clarity
A structured second opinion is useful if:
- Drops were advised but not clearly explained
- You were told to “just start” without understanding risk
- You want to know if observation is still safe
- You want treatment decisions aligned with long-term outcomes
- You want a risk benefit analysis, along with a clear understanding of side effects of glaucoma eyedrops, and other treatment options
Good glaucoma care should feel calm, reasoned, and proportional. It is not rushed or fear-driven. And all your questions must be answered. Especially, when to start glaucoma eyedrops.
Glaucoma Second Opinion Gurgaon
Frequently Asked Questions
Should I start glaucoma eyedrops if my vision is perfectly normal?
Possibly yes, and this is the part that surprises most patients. Glaucoma damages the optic nerve long before vision loss becomes noticeable in daily life. The brain compensates remarkably well for early peripheral nerve damage. By the time you notice something is wrong, the loss is usually permanent. Eyedrops are prescribed to prevent that loss from happening, not to treat vision that has already gone.
How does a doctor decide it is time to start glaucoma drops?
The decision is based on several factors together, not pressure alone. These include the appearance and health of the optic nerve, OCT scan findings, visual field results, corneal thickness, family history, age, rate of any suspected progression, and systemic factors like blood pressure and sleep patterns. A high number on the pressure reading is not automatically enough to start treatment. A vulnerable nerve at modest pressure sometimes is.
What if I want to wait and observe before starting drops?
In some situations, observation is a reasonable choice, but it must be genuinely structured. That means scheduled follow-up appointments, repeat visual field tests, and repeat OCT scans at defined intervals. Simply doing nothing and returning only if symptoms appear is not safe observation. It is a gap in care. If observation has been suggested, ask specifically what will be monitored, how often, and what finding would trigger a change in plan.
Do glaucoma eyedrops improve vision?
No. Glaucoma eyedrops lower eye pressure to protect the optic nerve from further damage. They do not repair nerve fibres that have already been lost, and they do not improve existing vision. This is why starting early, before significant damage accumulates, matters so much. There is nothing to recover once nerve tissue is gone.
Are there alternatives to glaucoma eyedrops?
Yes. Laser treatment, particularly Selective Laser Trabeculoplasty (SLT), is an effective alternative for many patients, and in some cases may be a better first choice than drops. Glaucoma surgery is considered when drops and laser are insufficient. The right option depends on the type of glaucoma, the pressure target needed, and individual patient factors. A specialist evaluation can help clarify which approach makes most sense for your specific situation.
What are the risks of not starting glaucoma drops when recommended?
The main risk is continued optic nerve damage during the period of delay. Because glaucoma has no symptoms in its early stages, this damage accumulates silently. Once lost, peripheral vision cannot be restored. The longer a high-risk eye goes unprotected, the narrower the window to preserve functional vision for the decades ahead.
Can vascular problems affect whether I need glaucoma drops?
Yes, and this is an important and often overlooked factor. Low nocturnal blood pressure, sleep apnea, migraine, and peripheral vascular disease can all reduce blood flow to the optic nerve, independently of eye pressure. In these patients, the optic nerve may be more vulnerable even at normal or mildly elevated pressure. A thorough glaucoma evaluation considers systemic vascular health alongside eye pressure findings.
When should I get a second opinion before starting glaucoma drops? Seek a second opinion if drops were recommended without a clear explanation of why, if you were not told what would happen if you chose not to start, if you are uncertain whether the diagnosis is correct, or if you want to understand whether laser might be a better first step for you. A good second opinion does not replace your existing doctor, it gives you the information you need to make a confident, informed decision about a treatment you may be taking for the rest of your life.
Read the research articles
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
Available on Pubmed and Google Scholar
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
www.drshibalbhartiya.com
+91 88826 38735
